\-\ Texto\\:\\ \ \(0\)\
\-\ normal\ \(4026\)\
\-\ resection\\ of\\ tumor\ \(4\)\
\-\ no\\ chemotherapy\\ or\\ radiation\\ therapy\\ at\\ present\ \(0\)\
\-\ \\â\\€\\¢\\ right\\ frontal\\ lobe\\ intra\\-axial\\ lesion\\ \\-\\ subcortical\\ wm\ \(0\)\
\-\ \\â\\€\\¢\\ hypointense\\ on\\ t1\\ images\ \(0\)\
\-\ \\â\\€\\¢\\ hyperintense\\ on\\ both\\ t2\\ and\\ flair\\ images\ \(0\)\
\-\ \\â\\€\\¢\\ no\\ enhancement\\ following\\ contrast\\ administration\ \(0\)\
\-\ astrocytoma\\ grade\\ ii\\ \\(diffuse\\)\ \(0\)\
\-\ \\â\\€\\¢\\ infarction\ \(0\)\
\-\ \\â\\€\\¢\\ cerebritis\ \(1\)\
\-\ \\â\\€\\¢\\ contusion\ \(1\)\
\-\ \\â\\€\\¢\\ hamartoma\ \(0\)\
\-\ \\â\\€\\¢\\ neoplasm\ \(1\)\
\-\ 28\\ y\\.o\\.\\ man\\ with\\ a\\ two\\ month\\ history\\ of\\ headaches\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.21049446513974612\ \(0\)\
\-\ intra\\-axial\\:\\ 0\\.0911562421323028\ \(0\)\
\-\ cerebritis\\:\\ 0\\.09019298062278681\ \(0\)\
\-\ wm\\:\\ 0\\.08081076182543795\ \(0\)\
\-\ subcortical\\:\\ 0\\.07768060464660109\ \(0\)\
\-\ contusion\\:\\ 0\\.0702185755193013\ \(0\)\
\-\ hamartoma\\:\\ 0\\.06973707011305919\ \(0\)\
\-\ hypointense\\:\\ 0\\.060497678942817046\ \(0\)\
\-\ 28\\:\\ 0\\.06011980121170825\ \(0\)\
\-\ flair\\:\\ 0\\.058472815283814726\ \(0\)\
\-\ ii\\:\\ 0\\.05500924938870783\ \(0\)\
\-\ hyperintense\\:\\ 0\\.05295015320751\ \(0\)\
\-\ administration\\:\\ 0\\.05295015320751\ \(0\)\
\-\ infarction\\:\\ 0\\.052126991713852086\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.04952761490557158\ \(0\)\
\-\ images\\:\\ 0\\.04893325050595087\ \(0\)\
\-\ headaches\\:\\ 0\\.04875287073240714\ \(0\)\
\-\ grade\\:\\ 0\\.04857965362613388\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.045715608733445746\ \(0\)\
\-\ neoplasm\\:\\ 0\\.043435172774804895\ \(0\)\
\-\ radiation\\:\\ 0\\.041854496262124424\ \(0\)\
\-\ t1\\:\\ 0\\.04042530651080961\ \(0\)\
\-\ frontal\\:\\ 0\\.040064058723632195\ \(0\)\
\-\ resection\\:\\ 0\\.039774860530152514\ \(0\)\
\-\ diffuse\\:\\ 0\\.038612051050377835\ \(0\)\
\-\ month\\:\\ 0\\.038262903594038944\ \(0\)\
\-\ y\\.o\\:\\ 0\\.036811633322189556\ \(0\)\
\-\ two\\:\\ 0\\.0365273319047165\ \(0\)\
\-\ following\\:\\ 0\\.03619817547613654\ \(0\)\
\-\ t2\\:\\ 0\\.0360983398320948\ \(0\)\
\-\ lobe\\:\\ 0\\.03431828877497812\ \(0\)\
\-\ enhancement\\:\\ 0\\.03418639949437367\ \(0\)\
\-\ therapy\\:\\ 0\\.03409911636180019\ \(0\)\
\-\ both\\:\\ 0\\.03257014911471823\ \(0\)\
\-\ man\\:\\ 0\\.030163161837164165\ \(0\)\
\-\ tumor\\:\\ 0\\.029734810471803153\ \(0\)\
\-\ present\\:\\ 0\\.028806100804950458\ \(0\)\
\-\ contrast\\:\\ 0\\.028548890847879184\ \(0\)\
\-\ \\-\\:\\ 0\\.0273392307269905\ \(0\)\
\-\ lesion\\:\\ 0\\.025978436208962008\ \(0\)\
\-\ no\\:\\ 0\\.025684900021009014\ \(0\)\
\-\ on\\:\\ 0\\.021608686936281436\ \(0\)\
\-\ normal\\:\\ 0\\.01999421574028509\ \(0\)\
\-\ history\\:\\ 0\\.017615142353837064\ \(0\)\
\-\ at\\:\\ 0\\.017280047057188552\ \(0\)\
\-\ or\\:\\ 0\\.014948100730801604\ \(0\)\
\-\ right\\:\\ 0\\.013457189688215174\ \(0\)\
\-\ \\(\\:\\ 0\\.010781518302147172\ \(0\)\
\-\ \\)\\:\\ 0\\.010649816300198582\ \(0\)\
\-\ a\\:\\ 0\\.005919400027143302\ \(0\)\
\-\ of\\:\\ 0\\.0034777253969548783\ \(0\)\
\-\ and\\:\\ 0\\.002686701578092813\ \(0\)\
\-\ with\\:\\ 0\\.0017463309864162648\ \(0\)\
\-\ \\.\\:\\ 0\\.0010596876446969036\ \(0\)\
